Objective:

To present the case of a 32-year-old female patient with a diagnosis of stiff person syndrome, with multiple treatments for pain and spasticity without response, with an intrathecal baclofen test with a positive response, so a definitive implantable device was placed for administration of intrathecal medication (baclofen), performed at the National Medical Center November 20 of the ISSSTE with an improvement of more than 80 % in terms of pain, decreased spasticity.

Methodology:

Presentation of clinical case, descriptive and observational study carried out in the National Medical Center November 20, of Mexico City, with follow-up of the patient and its evolution for a period of 12 months between 2017 and 2018.

Results:

After the trial with a single dose of intrathecal baclofen, the permanent device was placed for administration of intrathecal baclofen, in the last consultation with a dose of 300 micrograms a day, with an improvement of pain of more than 80 % and with improvement of 100 % in spasticity and overall improvement of the symptoms and with the reincorporation to his habitual life.

Conclusions:

The use of intrathecal baclofen should be considered an optimal and real alternative for the treatment of rigid person syndrome through intrathecal administration in Mexico.

        · resumen en Español     · texto en Español     · Español ( pdf )